Is Gait Speed and Sarcopenia Prognostic in Chronic Respiratory Disease?
Completed
- Conditions
- Chronic Obstructive Pulmonary Disease and Allied Conditions
- Registration Number
- NCT02261337
- Lead Sponsor
- Royal Brompton & Harefield NHS Foundation Trust
- Brief Summary
This study aims to assess usual walking speed (4-metre gait speed) and markers of sarcopenia predict mortality in patients with chronic respiratory disease.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 565
Inclusion Criteria
- All patients with chronic respiratory disease who are able to complete the assessments.
Exclusion Criteria
- Significant co-morbidities that would limit walking ability, exercise capacity or make exercise unsafe (e.g. unstable ischaemic heart disease, neuromuscular disease, severe hip/lower limb joint pain, peripheral vascular disease, lower limb amputation).
- Any patient whom the Chief Investigator feels it is unsafe to exercise (e.g. unstable cardiovascular disease).
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Number of participant deaths 1 year
- Secondary Outcome Measures
Name Time Method Number of exacerbations as defined by a worsening of symptoms that warrant a change in medication. 1 and 2 years Number of participant deaths 2 years and 5 years Number of hospital admissions 1 and 2 years Number of patients admitted to a nursing home 2 and 5 years Number of hospital bed days 1 and 2 years
Trial Locations
- Locations (1)
Harefield hospital
🇬🇧Harefield, Middlesex, United Kingdom